Corsair Capital Management - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Corsair Capital Management ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$103,01847,2560.04%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lindbrook Capital, LLC 383,351$4,611,7130.57%
Private Portfolio Partners LLC 53,600$644,8080.17%
Draper Asset Management, LLC 9,974$119,9870.17%
Draper Asset Management, LLC 20,000$115,3340.16%
XTX Topco Ltd 57,083$686,7080.15%
GSA CAPITAL PARTNERS LLP 46,039$5540.07%
Glass Jacobson Investment Advisors llc 9,350$112,4800.06%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 26,220$315,4270.05%
OCCUDO QUANTITATIVE STRATEGIES LP 20,515$246,7950.03%
Lighthouse Investment Partners, LLC 17,227$207,2410.02%
View complete list of ORAMED PHARMACEUTICALS INC shareholders